Back
Speaker illustration

Doctor Queenie Chan

Amgen Ltd, Greater London (United Kingdom of Great Britain & Northern Ireland)

Presentations

Lipid management in high cardiovascular risk patients without prior myocardial infarction or stroke - preliminary data from the VESALIUS-REAL global burden study

Event: ESC Congress 2025

Topic: Lipid-Lowering Agents

Session: Improving pharmacotherapy in primary prevention

Access
Like
Thumbnail

Global burden of high-risk cardiovascular patients without prior myocardial infarction or stroke: VESALIUS-REAL - preliminary results from Germany

Event: ESC Congress 2024

Topic: Cardiovascular Epidemiology

Session: Cardiovascular risk prediction, mortality disparities, and equity in cardiology research: global insights

Access
Like
Thumbnail

Characteristics of patients initiating PCSK9i mAb following myocardial infarction and comparability of treatment groups in the Netherlands

Event: ESC Congress 2023

Topic: Lipid-Lowering Agents

Session: PCSK9 inhibitors and inclisiran

Access
Like
Thumbnail

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources